for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fresenius Medical Care AG & Co. KGaA

FMEG.DE

Latest Trade

63.02EUR

Change

-0.62(-0.97%)

Volume

1,515,007

Today's Range

62.28

 - 

63.68

52 Week Range

55.44

 - 

91.74

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
63.64
Open
63.66
Volume
1,515,007
3M AVG Volume
18.00
Today's High
63.68
Today's Low
62.28
52 Week High
91.74
52 Week Low
55.44
Shares Out (MIL)
302.85
Market Cap (MIL)
19,180.36
Forward P/E
15.31
Dividend (Yield %)
1.86

Next Event

Fresenius Medical Care AG & Co KGaA at Sanford C Bernstein Strategic Decisions CEO Conference

Latest Developments

More

HCA Healthcare Inc - Announced Purchase Of 24 Medspring Urgent Care Centers From Fresenius Medical Care

Fresenius Medical Care To Implement Share Buy-Back Programme

Fresenius Medical Care Places $500 Mln 10-Yr Bonds With 3.94% Yield

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

Industry

Healthcare Facilities

Contact Info

Else-Kroener-Strasse 1

+49.6172.6090

https://www.freseniusmedicalcare.com/

Executive Leadership

Dieter Schenk

Chairman of the Supervisory Board

Rice Powell

Chairman of the Management Board, Chief Executive Officer

Ben J. Lipps

Honorary Chairman

Rolf A. Classon

Independent Vice Chairman of the Supervisory Board

Michael Brosnan

Chief Financial Officer, Member of the Management Board

Key Stats

2.25 mean rating - 24 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

17.0K

2017

17.8K

2018

16.5K

2019(E)

17.3K
EPS (EUR)

2016

3.862

2017

4.170

2018

4.490

2019(E)

4.132
Price To Earnings (TTM)
15.68
Price To Sales (TTM)
1.14
Price To Book (MRQ)
1.64
Price To Cash Flow (TTM)
7.37
Total Debt To Equity (MRQ)
115.52
LT Debt To Equity (MRQ)
84.83
Return on Investment (TTM)
7.06
Return on Equity (TTM)
5.20

Latest News

Fresenius Medical Care appoints Takeda executive Helen Giza as CFO

German dialysis specialist Fresenius Medical Care <FMEG.DE> has hired Helen Giza from Japan's Takeda Pharmaceutical <4502.T> as its new finance chief, replacing Mike Brosnan.

Fresenius slides as weakness in dialysis unit offsets improved outlook

Shares in German healthcare group Fresenius <FREG.DE> slid on Tuesday after its dialysis unit FMC reported smaller than expected cost savings and said full-year earnings growth would likely come in at the lower end of guidance.

Fresenius Medical Care confirms 2019 targets

German dialysis specialist Fresenius Medical Care <FMEG.DE> reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

Shareholders reproach Germany's Fresenius Medical Care after foreign bribery case

* ISS recommends no confidence vote on U.S. bribery settlement

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges

Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice...

FMC wraps up $2 bln acquisition of NxStage

Germany's Fresenius Medical Care (FMC) wrapped up its $2 billion acquisition of U.S. home dialysis maker NxStage Medical on Friday, according to a U.S. Securities and Exchange Commission filing.

Fresenius flags faster earnings growth from 2020 after investment

Fresenius expects earnings to grow faster than sales from 2020 after investments to improve its German hospitals and scale up its home dialysis business eat up profit this year, the German healthcare group said on Wednesday.

FMC expects NxStage deal to close in next couple of days

Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

RPT-Fresenius Medical Care plans 1 bln eur share buyback

Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

Fresenius Medical Care plans 1 bln eur share buyback

Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

Fresenius expects earnings to stagnate in 2019 as investments weigh

German healthcare group Fresenius said sales growth would slow and profit stagnate this year as investments to fix the performance at its German hospitals business and build up home dialysis take a toll.

U.S. approves Fresenius purchase of NxStage

The U.S. Federal Trade Commission has given Germany's Fresenius Medical Care AG and U.S. home dialysis equipment maker NxStage Medical Inc antitrust approval for their merger, the agency said on Tuesday.

US approves Fresenius purchase of NxStage with conditions

The U.S. Federal Trade Commission has given Fresenius Medical Care AG and NxStage Medical Inc antitrust approval for their merger with conditions, the agency said on Tuesday. (Reporting by Diane Bartz Editing by James Dalgleish)

FMC extends deadline for NxStage deal until Aug. 6 due to U.S. government shutdown

Germany's Fresenius Medical Care (FMC) said on Tuesday it had agreed to extend the deadline for its planned $2 billion takeover of U.S. home dialysis equipment maker NxStage Medical Inc until August 6.

Germany's Fresenius Medical Care snaps up stakes in Chinese hospitals

Germany's Fresenius Medical Care <FMEG.DE> (FMC) has acquired several stakes in Chinese kidney hospitals and dialysis clinics as it seeks to expand in the world's second-biggest market for dialysis by patient numbers.

Fresenius Medical Care says expects weaker growth in fourth quarter

Germany's Fresenius Medical Care <FMEG.DE> (FMC) has identified measures to accelerate growth in its dialysis business but said weaker performance would continue in the fourth quarter.

Fresenius says working to fix performance at dialysis business, German hospitals

Germany's Fresenius <FREG.DE> said it was putting measures in place to improve growth at its dialysis and German hospitals businesses after a weaker performance of these units prompted the group to narrow its guidance earlier this month.

Fresenius Medical Care says expects weaker growth in Q4

Germany's Fresenius Medical Care warned it expected slower growth to continue in the fourth quarter after weaker-than-expected growth prompted the group to cut its earnings guidance earlier this month.

UPDATE 1-Fresenius Medical cuts 2018 targets, sending shares tumbling

* FMC shares slump 13.7 pct, Fresenius down 8.9 pct (Recasts, adds outlook, analyst, trader comment, changes dateline)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up